✨ Your Portfolio is fetched and updated from zerodha.
Large Pharmaceuticals
Market Cap
₹1,13,007 Cr.
P/E
29.13
  • Cipla
  • Dr. Reddy's Lab
  • Zydus Lifesciences
  • TJI Pharma

FAQs on Cipla Ltd. Shareprice

Cipla has given lower returns compared to its competitors.
Cipla has grown at ~14.26% over the last 3yrs while peers have grown at a median rate of 34.34%

Yes, Cipla is expensive.
Latest PE of Cipla is 32.15, while 3 year average PE is 28.31.
Also latest EV/EBITDA of Cipla is 18.9 while 3yr average is 17.56.

Growth Table

  • Cipla Ltd.
  • Dr. Reddy's Lab
  • Zydus Lifesciences

Balance Sheet

  • Cipla Ltd.
  • Dr. Reddy's Lab
  • Zydus Lifesciences

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Cipla Ltd.
  • Dr. Reddy's Lab
  • Zydus Lifesciences

Cash Flow

  • Cipla Ltd.
  • Dr. Reddy's Lab
  • Zydus Lifesciences

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Cipla Ltd.
  • Dr. Reddy's Lab
  • Zydus Lifesciences

Quarterly Results

  • Cipla Ltd.
  • Dr. Reddy's Lab
  • Zydus Lifesciences

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*

FAQs on Cipla Ltd. Financials

Balance sheet of Cipla is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Cipla is increasing.
Latest net debt of Cipla is -₹1,049.45 Crs as of Mar-26.
This is greater than Mar-25 when it was -₹1,500.02 Crs.

The profit is oscillating.
The profit of Cipla is ₹3,870 Crs for TTM, ₹5,273 Crs for Mar 2025 and ₹4,122 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Cipla latest dividend payout ratio is 24.51% and 3yr average dividend payout ratio is 24.82%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech